CIK 0000805928 · Large accelerated filer
Axogen, Inc.
Sign in to watch- Ticker
- AXGN
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411301878
- Phone
- (386) 462-6817
- Business address
- 13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL, 32615
- Former names
- LECTEC CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $173,940
- in 1 filing, $174K under 10b5-1 plans
Net −$173,940. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-16 | Donovan Michael Patrick VP Operations | Option exercise · Restricted Stock Units | −3,000 | 3,000 | ||
| 2023-03-16 | Donovan Michael Patrick VP Operations | Option exercise · Restricted Stock Units | −5,900 | 5,900 | ||
| 2023-03-16 | Donovan Michael Patrick VP Operations | Grant or award · Employee Stock Option (right to purchase) | +63,500 | 63,500 | ||
| 2023-03-16 | Donovan Michael Patrick VP Operations | Grant or award · Restricted Stock Units | +48,500 | 48,500 | ||
| 2023-03-16 | DeVinney Erick Wayne VP Peripheral Nerve Science | Option exercise | +5,900 | 112,431 | ||
| 2023-03-16 | DeVinney Erick Wayne VP Peripheral Nerve Science | Shares withheld for taxes | −1,835 | $8.27 | $15K | 110,596 |
| 2023-03-16 | DeVinney Erick Wayne VP Peripheral Nerve Science | Option exercise | +3,000 | 113,596 | ||
| 2023-03-16 | DeVinney Erick Wayne VP Peripheral Nerve Science | Shares withheld for taxes | −934 | $8.27 | $8K | 112,662 |
| 2023-03-16 | DeVinney Erick Wayne VP Peripheral Nerve Science | Option exercise · Restricted Stock Units | +5,900 | 5,900 | ||
| 2023-03-16 | DeVinney Erick Wayne VP Peripheral Nerve Science | Option exercise · Restricted Stock Units | +3,000 | 3,000 | ||
| 2023-03-16 | DeVinney Erick Wayne VP Peripheral Nerve Science | Grant or award · Employee Stock Option (right to purchase) | +64,000 | 64,000 | ||
| 2023-03-16 | DeVinney Erick Wayne VP Peripheral Nerve Science | Grant or award · Restricted Stock Units | +46,300 | 46,300 | ||
| 2023-03-16 | Zaderej Karen L. CEO | Option exercise | +25,000 | 1,037,695 | ||
| 2023-03-16 | Zaderej Karen L. CEO | Option exercise | +12,975 | 1,050,670 | ||
| 2023-03-16 | Zaderej Karen L. CEO | Option exercise · Restricted Stock Units | −25,000 | 25,000 | ||
| 2023-03-16 | Zaderej Karen L. CEO | Option exercise · Restricted Stock Units | −12,975 | 12,975 | ||
| 2023-03-16 | Zaderej Karen L. CEO | Grant or award · Employee Stock Option (right to purchase) | +179,000 | 179,000 | ||
| 2023-03-16 | Zaderej Karen L. CEO | Grant or award · Restricted Stock Units | +112,000 | 112,000 | ||
| 2023-03-16 | Ottinger Bradley General Counsel and CCO | Option exercise | +5,900 | 23,698 | ||
| 2023-03-16 | Ottinger Bradley General Counsel and CCO | Shares withheld for taxes | −798 | $8.27 | $7K | 22,900 |
Page 19 of 61 · 1,220 trades